India's Cadila gets FDA warning for violating standards at 2 plants

MUMBAI (Reuters) - India's Cadila Healthcare Ltd said it had received a "warning letter" from the U.S. Food and Drug Administration for violating manufacturing standards at two of its production sites in India, sending its shares down 15 percent on Thursday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro